changes for a new millennium
TRANSCRIPT
Journal of Clinical Immunology, Vol. 19, No. 3, 1999
Editorial
Changes for a New Millennium
There has been a proliferation of the number of journalsin the field of immunology. Some journals have beendiscontinued, while others have changed their names. Inthe midst of these changes, the Journal of ClinicalImmunology continues to grow and expand its scope. TheJournal is entering the new millennium and the twentiethyear of its publication. Over the years, it has establisheditself as a high-quality immunology journal that is citedin Index Medicus, Current Contents, and other keyindices. Currently, the scope of the Journal of ClinicalImmunology has expanded to include basic, cellular, andmolecular immunology and to experimental models ofhuman diseases.
The Journal is now embarking on further changes thatwill further serve both current and new readers. Theseinclude the addition of a Key Feature in each issue. TheKey Feature will present four to five invited mini-reviewarticles on a current hot topic in immunology. Thisfeature begins in this issue with articles on Chemokines
and Chemokine Receptors. The next issue will featureApoptosis, followed by Stem Cell Transplantation inAutoimmune Diseases. In each issue, the Key Featurewill be followed by high-quality original articles onvarious aspects of basic, cellular, molecular, and clinicalimmunology topics. The review process of originalmanuscripts will be approximately four weeks, andmanuscripts will be published within approximately fourmonths of acceptance.
Finally, the Journal of Clinical Immunology will beon-line beginning January 2000.
I thank my distinguished Associate Editors, AdvisoryBoard, and Editorial Board for their continuing contri-butions to the changes and growth of the Journal. Weplan to maintain the Journal of Clinical Immunology'sstature as a fine journal in the field of immunology.
SUDHIR GUPTA, M.D., PH.D.Editor, Journal of Clinical Immunology
2490271-9142/99/0900-0249$16.00/0 C 1999 Plenum Publishing Corporation